id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
---|---|---|---|---|---|
NCT03159702 | 30:54:cancer | Patients with a diagnosis of hematological malignancy undergoing a related donor haploidentical HCT | 1 | [
"Patients",
"with",
"a",
"diagnosis",
"of",
"hematological",
"malignancy",
"undergoing",
"a",
"related",
"donor",
"haploidentical",
"HCT"
] | [
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT03008408 | 23:47:chronic_disease,,, | History of documented congestive heart failure (New York Heart Association functional classification III-IV) | 1 | [
"History",
"of",
"documented",
"congestive",
"heart",
"failure",
"(",
"New",
"York",
"Heart",
"Association",
"functional",
"classification",
"III-IV",
")"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02734602 | 42:51:chronic_disease,53:57:chronic_disease,62:78:chronic_disease | No first-degree relative with history of psychotic, mood, or anxiety disorder | 1 | [
"No",
"first-degree",
"relative",
"with",
"history",
"of",
"psychotic",
",",
"mood",
",",
"or",
"anxiety",
"disorder"
] | [
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT01807091 | ,,,87:99:treatment | Treatment-related mortality (TRM) score < 9.21 corresponding to a TRM rate of 3% when chemotherapy of similar intensity as proposed here is administered to inpatients | 1 | [
"Treatment-related",
"mortality",
"(",
"TRM",
")",
"score",
"<",
"9.21",
"corresponding",
"to",
"a",
"TRM",
"rate",
"of",
"3",
"%",
"when",
"chemotherapy",
"of",
"similar",
"intensity",
"as",
"proposed",
"here",
"is",
"administered",
"to",
"inpatients"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02191098 | 21:63:chronic_disease,74:83:treatment,88:107:treatment | Active or recurrent herpes or varicella-zoster virus infection requiring treatment (or chronic suppression) | 1 | [
"Active",
"or",
"recurrent",
"herpes",
"or",
"varicella-zoster",
"virus",
"infection",
"requiring",
"treatment",
"(",
"or",
"chronic",
"suppression",
")"
] | [
0,
0,
0,
2,
2,
2,
2,
2,
0,
1,
0,
0,
1,
1,
0
] |
NCT01976585 | 25:34:treatment | Able to comply with the treatment schedule | 1 | [
"Able",
"to",
"comply",
"with",
"the",
"treatment",
"schedule"
] | [
0,
0,
0,
0,
0,
1,
0
] |
NCT02604277 | 12:38:chronic_disease | History of mood incongruent psychotic symptoms | 1 | [
"History",
"of",
"mood",
"incongruent",
"psychotic",
"symptoms"
] | [
0,
0,
2,
2,
2,
0
] |
NCT02503722 | 1:20:chronic_disease,38:44:chronic_disease,55:62:treatment,67:91:treatment | Ischemic myocardial event, including angina requiring therapy and artery revascularization procedures | 1 | [
"Ischemic",
"myocardial",
"event",
",",
"including",
"angina",
"requiring",
"therapy",
"and",
"artery",
"revascularization",
"procedures"
] | [
2,
2,
0,
0,
0,
2,
0,
1,
0,
1,
1,
0
] |
NCT03151330 | 7:30:chronic_disease | Known fetal genetic anomalies that are incompatible with life | 1 | [
"Known",
"fetal",
"genetic",
"anomalies",
"that",
"are",
"incompatible",
"with",
"life"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02342808 | 8:30:chronic_disease,32:55:chronic_disease,71:79:chronic_disease, | Severe ischemic heart disease (CCS Class 3 or 4 angina or evidence of ischemia at <85% heart rate reserve on treadmill testing) | 1 | [
"Severe",
"ischemic",
"heart",
"disease",
"(",
"CCS",
"Class",
"3",
"or",
"4",
"angina",
"or",
"evidence",
"of",
"ischemia",
"at",
"<",
"85",
"%",
"heart",
"rate",
"reserve",
"on",
"treadmill",
"testing",
")"
] | [
0,
2,
2,
2,
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02308709 | ,22:31:treatment, | Life expectancy with treatment should be ≥6 months in the estimation of the treating physicians | 1 | [
"Life",
"expectancy",
"with",
"treatment",
"should",
"be",
"≥6",
"months",
"in",
"the",
"estimation",
"of",
"the",
"treating",
"physicians"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01849146 | 35:48:treatment | recovered from severe toxicity of prior therapy | 1 | [
"recovered",
"from",
"severe",
"toxicity",
"of",
"prior",
"therapy"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT02094118 | 1:34:chronic_disease | Immunoglobulin A (IgA) deficiency | 1 | [
"Immunoglobulin",
"A",
"(",
"IgA",
")",
"deficiency"
] | [
2,
2,
2,
2,
0,
0
] |
NCT00291525 | 1:19:chronic_disease | Vascular pathology | 1 | [
"Vascular",
"pathology"
] | [
2,
2
] |
NCT02321501 | 1:24:chronic_disease,13:24:chronic_disease,26:42:chronic_disease,85:95:treatment | ventricular arrhythmias; supraventricular and nodal arrhythmias not controlled with medication | 1 | [
"ventricular",
"arrhythmias",
";",
"supraventricular",
"and",
"nodal",
"arrhythmias",
"not",
"controlled",
"with",
"medication"
] | [
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
1
] |
NCT02236013 | 18:50:treatment | Subject requires treatment with concomitant drugs that target serotonin 5HT1R or 5HT2BR receptors or sigma nonspecific receptor with the exception of drugs that are considered absolutely essential for the care of the subject | 1 | [
"Subject",
"requires",
"treatment",
"with",
"concomitant",
"drugs",
"that",
"target",
"serotonin",
"5HT1R",
"or",
"5HT2BR",
"receptors",
"or",
"sigma",
"nonspecific",
"receptor",
"with",
"the",
"exception",
"of",
"drugs",
"that",
"are",
"considered",
"absolutely",
"essential",
"for",
"the",
"care",
"of",
"the",
"subject"
] | [
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00678145 | 27:35:chronic_disease | 1st degree relatives with diabetes | 1 | [
"1st",
"degree",
"relatives",
"with",
"diabetes"
] | [
0,
0,
0,
0,
2
] |
NCT01445821 | 18:28:cancer | Prior history of malignancy | 1 | [
"Prior",
"history",
"of",
"malignancy"
] | [
0,
0,
0,
3
] |
NCT02020707 | 1:28:treatment,, | Therapeutic anticoagulation requiring international normalized ratio (INR) > 2.0 | 1 | [
"Therapeutic",
"anticoagulation",
"requiring",
"international",
"normalized",
"ratio",
"(",
"INR",
")",
">",
"2.0"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03118973 | 39:43:treatment | Patient has a clinical indication for ERCP | 1 | [
"Patient",
"has",
"a",
"clinical",
"indication",
"for",
"ERCP"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT02519452 | 4:32:treatment,43:54:treatment,56:68:treatment,70:82:treatment,118:127:treatment | an immunomodulatory drug (IMiD) (example, thalidomide, lenalidomide, pomalidomide) in any order during the course of treatment | 1 | [
"an",
"immunomodulatory",
"drug",
"(",
"IMiD",
")",
"(",
"example",
",",
"thalidomide",
",",
"lenalidomide",
",",
"pomalidomide",
")",
"in",
"any",
"order",
"during",
"the",
"course",
"of",
"treatment"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01822522 | 25:37:chronic_disease,,,,,131:165:treatment,156:165:treatment, | Concurrent uncontrolled hypertension defined as sustained blood pressure (BP) > 140 mmHg systolic, or > 90 mmHg diastolic despite optimal antihypertensive treatment within 7 days of the first dose of study treatment | 1 | [
"Concurrent",
"uncontrolled",
"hypertension",
"defined",
"as",
"sustained",
"blood",
"pressure",
"(",
"BP",
")",
">",
"140",
"mmHg",
"systolic",
",",
"or",
">",
"90",
"mmHg",
"diastolic",
"despite",
"optimal",
"antihypertensive",
"treatment",
"within",
"7",
"days",
"of",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02774421 | 28:40:treatment | who have been treated with chemotherapy at time of recurrence | 1 | [
"who",
"have",
"been",
"treated",
"with",
"chemotherapy",
"at",
"time",
"of",
"recurrence"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02171429 | 25:46:treatment | Naive to treatment with TNF inhibitor therapy | 1 | [
"Naive",
"to",
"treatment",
"with",
"TNF",
"inhibitor",
"therapy"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT02489045 | 68:82:chronic_disease | Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable | 1 | [
"Patients",
"who",
"are",
"medically",
"unstable",
",",
"patients",
"who",
"are",
"seriously",
"or",
"terminally",
"ill",
",",
"and",
"patients",
"whose",
"clinical",
"course",
"is",
"unpredictable"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02494869 | 8:20:chronic_disease | Active endocarditis | 1 | [
"Active",
"endocarditis"
] | [
0,
2
] |
NCT03040778 | 1:14:treatment | ciprofloxacin | 1 | [
"ciprofloxacin"
] | [
1
] |
NCT02101944 | 30:64:chronic_disease,85:96:chronic_disease,100:101:chronic_disease | Patients must not have known human immunodeficiency virus (HIV) infection or active hepatitis B or C infections | 1 | [
"Patients",
"must",
"not",
"have",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection",
"or",
"active",
"hepatitis",
"B",
"or",
"C",
"infections"
] | [
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0
] |
NCT02703220 | 15:33:chronic_disease,, | Patients with severe sleep apnea (AHI>20/hr) | 1 | [
"Patients",
"with",
"severe",
"sleep",
"apnea",
"(",
"AHI",
">",
"20/hr",
")"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02565498 | 24:66:treatment | Deemed appropriate for preoperative or postoperative radiotherapy | 1 | [
"Deemed",
"appropriate",
"for",
"preoperative",
"or",
"postoperative",
"radiotherapy"
] | [
0,
0,
0,
1,
1,
1,
1
] |
NCT02215096 | 21:55:chronic_disease | A positive test for human immunodeficiency virus (HIV) antibody (testing at time of screening is not required) | 1 | [
"A",
"positive",
"test",
"for",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"antibody",
"(",
"testing",
"at",
"time",
"of",
"screening",
"is",
"not",
"required",
")"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02226159 | 1:9:chronic_disease,, | diabetes (type I or type II) | 1 | [
"diabetes",
"(",
"type",
"I",
"or",
"type",
"II",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02498951 | 18:28:cancer | History of other malignancy that could affect compliance with the protocol or interpretation of results | 1 | [
"History",
"of",
"other",
"malignancy",
"that",
"could",
"affect",
"compliance",
"with",
"the",
"protocol",
"or",
"interpretation",
"of",
"results"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03129061 | 12:24:treatment, | Received a live vaccine within 30 days of planned PD-1 start date | 1 | [
"Received",
"a",
"live",
"vaccine",
"within",
"30",
"days",
"of",
"planned",
"PD-1",
"start",
"date"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02593123 | 1:20:chronic_disease | bacterial infection | 1 | [
"bacterial",
"infection"
] | [
2,
2
] |
NCT02466009 | 24:33:treatment | Previous assignment to treatment during this study. Subjects permanently withdrawn from study participation will not be allowed to re-enter study | 1 | [
"Previous",
"assignment",
"to",
"treatment",
"during",
"this",
"study",
".",
"Subjects",
"permanently",
"withdrawn",
"from",
"study",
"participation",
"will",
"not",
"be",
"allowed",
"to",
"re-enter",
"study"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02942095 | 28:54:cancer,59:91:cancer,123:171:treatment | first 5 patients from both non-small cell lung cancer and pancreatic ductal adenocarcinoma patients will need to agree to mandatory pre- and post-treatment tumor biopsies | 1 | [
"first",
"5",
"patients",
"from",
"both",
"non-small",
"cell",
"lung",
"cancer",
"and",
"pancreatic",
"ductal",
"adenocarcinoma",
"patients",
"will",
"need",
"to",
"agree",
"to",
"mandatory",
"pre-",
"and",
"post-treatment",
"tumor",
"biopsies"
] | [
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT01570998 | 1:19:treatment | Prior chemotherapy | 1 | [
"Prior",
"chemotherapy"
] | [
1,
1
] |
NCT02650206 | 1:32:chronic_disease | Pancreatitis (acute or chronic) | 1 | [
"Pancreatitis",
"(",
"acute",
"or",
"chronic",
")"
] | [
2,
2,
2,
2,
0,
0
] |
NCT03183388 | 12:34:chronic_disease,58:69:chronic_disease,,129:145:chronic_disease,147:162:chronic_disease,166:183:cancer,188:214:chronic_disease | history of neurologic abnormality, including significant head trauma (defined by loss of consciousness of ≥5-minutes duration), seizure disorder, cerebrovascular or neoplastic lesion, or neurodegenerative disorder | 1 | [
"history",
"of",
"neurologic",
"abnormality",
",",
"including",
"significant",
"head",
"trauma",
"(",
"defined",
"by",
"loss",
"of",
"consciousness",
"of",
"≥5-minutes",
"duration",
")",
",",
"seizure",
"disorder",
",",
"cerebrovascular",
"or",
"neoplastic",
"lesion",
",",
"or",
"neurodegenerative",
"disorder"
] | [
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
3,
3,
0,
0,
2,
2
] |
NCT02660528 | 23:41:chronic_disease,53:71:chronic_disease,76:102:chronic_disease | History of or current autoimmune disease, including multiple sclerosis and inflammatory bowel disease | 1 | [
"History",
"of",
"or",
"current",
"autoimmune",
"disease",
",",
"including",
"multiple",
"sclerosis",
"and",
"inflammatory",
"bowel",
"disease"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
2
] |
NCT02047474 | 10:20:cancer, | No other malignancy within past five years | 1 | [
"No",
"other",
"malignancy",
"within",
"past",
"five",
"years"
] | [
0,
0,
3,
0,
0,
0,
0
] |
NCT01522768 | ,,107:115:treatment | Patients aged 18 years or older, as no dosing or adverse event data are currently available on the use of afatinib in patients <18 years of age | 1 | [
"Patients",
"aged",
"18",
"years",
"or",
"older",
",",
"as",
"no",
"dosing",
"or",
"adverse",
"event",
"data",
"are",
"currently",
"available",
"on",
"the",
"use",
"of",
"afatinib",
"in",
"patients",
"<",
"18",
"years",
"of",
"age"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03076333 | 40:57:treatment | Previous radiation exposure precluding radiation therapy | 1 | [
"Previous",
"radiation",
"exposure",
"precluding",
"radiation",
"therapy"
] | [
0,
1,
1,
0,
0,
0
] |
NCT02706288 | 1:26:chronic_disease | Polycystic ovary syndrome | 1 | [
"Polycystic",
"ovary",
"syndrome"
] | [
2,
2,
2
] |
NCT02942095 | 34:44:cancer, | Diagnosed or treated for another malignancy within 2 years before study enrollment or previously diagnosed with another malignancy and have any evidence of residual disease | 1 | [
"Diagnosed",
"or",
"treated",
"for",
"another",
"malignancy",
"within",
"2",
"years",
"before",
"study",
"enrollment",
"or",
"previously",
"diagnosed",
"with",
"another",
"malignancy",
"and",
"have",
"any",
"evidence",
"of",
"residual",
"disease"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02525029 | 13:23:cancer | Progressive malignancy | 1 | [
"Progressive",
"malignancy"
] | [
0,
3
] |
NCT03096288 | 4:13:treatment,23:41:treatment,53:60:treatment,65:76:treatment, | On treatment with any antiplatelet agent other than aspirin and clopidogrel in the past 14 days | 1 | [
"On",
"treatment",
"with",
"any",
"antiplatelet",
"agent",
"other",
"than",
"aspirin",
"and",
"clopidogrel",
"in",
"the",
"past",
"14",
"days"
] | [
0,
1,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0
] |
NCT02335242 | 18:40:treatment | Participating in another clinical study which may interfere | 1 | [
"Participating",
"in",
"another",
"clinical",
"study",
"which",
"may",
"interfere"
] | [
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT03059888 | 23:40:chronic_disease | Diagnosis of DEFINITE Myasthenia Gravis | 1 | [
"Diagnosis",
"of",
"DEFINITE",
"Myasthenia",
"Gravis"
] | [
0,
0,
0,
2,
2
] |
NCT02519322 | ,39:48:treatment | Within 2 weeks prior to time of study treatment | 1 | [
"Within",
"2",
"weeks",
"prior",
"to",
"time",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02315612 | 1:12:chronic_disease | Hematologic function | 1 | [
"Hematologic",
"function"
] | [
2,
0
] |
NCT02535312 | ,,53:59:treatment | Pregnant women are excluded from this study because TRC102 is agent with the potential for teratogenic or abortifacient effects | 1 | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"TRC102",
"is",
"agent",
"with",
"the",
"potential",
"for",
"teratogenic",
"or",
"abortifacient",
"effects"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02496208 | 1:28:chronic_disease | Active peptic ulcer disease | 1 | [
"Active",
"peptic",
"ulcer",
"disease"
] | [
2,
2,
2,
2
] |
NCT01434316 | 22:38:treatment,42:56:treatment,90:100:treatment | Subjects on a potent CYP3A4 inhibitor or CPY3A4 inducer who cannot be changed to another medication | 1 | [
"Subjects",
"on",
"a",
"potent",
"CYP3A4",
"inhibitor",
"or",
"CPY3A4",
"inducer",
"who",
"can",
"not",
"be",
"changed",
"to",
"another",
"medication"
] | [
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01570998 | 30:43:cancer | Axillary lymph node positive breast cancer | 1 | [
"Axillary",
"lymph",
"node",
"positive",
"breast",
"cancer"
] | [
0,
0,
0,
0,
3,
3
] |
NCT02553460 | 9:22:treatment | Limited prior therapy | 1 | [
"Limited",
"prior",
"therapy"
] | [
0,
1,
1
] |
NCT03085485 | 28:50:treatment,65:72:treatment,77:94:chronic_disease, | Subjects should not have a pulmonary exacerbation or changes in therapy for pulmonary disease within 28 days before receiving the first dose of study drug | 1 | [
"Subjects",
"should",
"not",
"have",
"a",
"pulmonary",
"exacerbation",
"or",
"changes",
"in",
"therapy",
"for",
"pulmonary",
"disease",
"within",
"28",
"days",
"before",
"receiving",
"the",
"first",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02278198 | 18:37:treatment,57:71:cancer,86:104:cancer,145:187:treatment | status post near total thyroidectomy for differentiated thyroid cancer without known distant metastases and who are planning to undergo routine remnant thyroid tissue ablation with I-131 | 1 | [
"status",
"post",
"near",
"total",
"thyroidectomy",
"for",
"differentiated",
"thyroid",
"cancer",
"without",
"known",
"distant",
"metastases",
"and",
"who",
"are",
"planning",
"to",
"undergo",
"routine",
"remnant",
"thyroid",
"tissue",
"ablation",
"with",
"I-131"
] | [
0,
0,
0,
1,
1,
0,
0,
3,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT02513797 | ,,35:58:treatment | LA diameter > 6 cm as measured by computerized tomography and confirmed by the imaging core laboratory | 1 | [
"LA",
"diameter",
">",
"6",
"cm",
"as",
"measured",
"by",
"computerized",
"tomography",
"and",
"confirmed",
"by",
"the",
"imaging",
"core",
"laboratory"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01505062 | 1:18:treatment,46:57:treatment,59:73:treatment,175:199:treatment | diagnostic agents used during the study (eg, fluorescein, dilation drops), or medications planned for use during the peri-operative period, particularly topical, injected or systemic corticosteroids | 1 | [
"diagnostic",
"agents",
"used",
"during",
"the",
"study",
"(",
"eg",
",",
"fluorescein",
",",
"dilation",
"drops",
")",
",",
"or",
"medications",
"planned",
"for",
"use",
"during",
"the",
"peri-operative",
"period",
",",
"particularly",
"topical",
",",
"injected",
"or",
"systemic",
"corticosteroids"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02108860 | ,,95:104:treatment | Both women and men must be willing to use an effective means of birth control while receiving treatment through this study | 1 | [
"Both",
"women",
"and",
"men",
"must",
"be",
"willing",
"to",
"use",
"an",
"effective",
"means",
"of",
"birth",
"control",
"while",
"receiving",
"treatment",
"through",
"this",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02519322 | 29:51:chronic_disease | Uncontrolled or significant cardiovascular disease | 1 | [
"Uncontrolled",
"or",
"significant",
"cardiovascular",
"disease"
] | [
0,
0,
0,
2,
2
] |
NCT03181516 | 1:20:treatment | Mefoxin (Cefoxitin) | 1 | [
"Mefoxin",
"(",
"Cefoxitin",
")"
] | [
1,
1,
0,
0
] |
NCT02548546 | 50:53:chronic_disease,, | Patients with either symptomatic or asymptomatic AAA as defined by aortic diameter ≥ 1.5x normal diameter | 1 | [
"Patients",
"with",
"either",
"symptomatic",
"or",
"asymptomatic",
"AAA",
"as",
"defined",
"by",
"aortic",
"diameter",
"≥",
"1.5x",
"normal",
"diameter"
] | [
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02430077 | 32:40:chronic_disease,,,, | Previous clinical diagnosis of diabetes mellitus or fasting blood glucose ≥ 126 mg/dL or hemoglobin A1c ≥ 6.5% | 1 | [
"Previous",
"clinical",
"diagnosis",
"of",
"diabetes",
"mellitus",
"or",
"fasting",
"blood",
"glucose",
"≥",
"126",
"mg/dL",
"or",
"hemoglobin",
"A1c",
"≥",
"6.5",
"%"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02347891 | ,,,,,,124:148:treatment | Clinically significant elevation of GGT (>1.5xULN), bilirubin (>1.25xULN, direct 35%), or INR (>1.2, excluding patients on anti-coagulant therapies) or other clinically significant abnormal laboratory value in the opinion of the investigator | 1 | [
"Clinically",
"significant",
"elevation",
"of",
"GGT",
"(",
">",
"1.5xULN",
")",
",",
"bilirubin",
"(",
">",
"1.25xULN",
",",
"direct",
"35",
"%",
")",
",",
"or",
"INR",
"(",
">",
"1.2",
",",
"excluding",
"patients",
"on",
"anti-coagulant",
"therapies",
")",
"or",
"other",
"clinically",
"significant",
"abnormal",
"laboratory",
"value",
"in",
"the",
"opinion",
"of",
"the",
"investigator"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02154568 | 21:38:chronic_disease | Negative history of pulmonary disease | 1 | [
"Negative",
"history",
"of",
"pulmonary",
"disease"
] | [
0,
0,
0,
2,
2
] |
NCT02862938 | 17:36:chronic_disease | Participant has optic nerve atrophy beyond modest pallor | 1 | [
"Participant",
"has",
"optic",
"nerve",
"atrophy",
"beyond",
"modest",
"pallor"
] | [
0,
0,
2,
2,
2,
0,
0,
0
] |
NCT02425904 | ,,,,,,,248:257:treatment | Female patients of childbearing potential must have a negative serum pregnancy test within 14 days prior to enrollment. Male and female patients must use an effective contraceptive method during the study and for a minimum of 6 months after study treatment | 1 | [
"Female",
"patients",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"within",
"14",
"days",
"prior",
"to",
"enrollment",
".",
"Male",
"and",
"female",
"patients",
"must",
"use",
"an",
"effective",
"contraceptive",
"method",
"during",
"the",
"study",
"and",
"for",
"a",
"minimum",
"of",
"6",
"months",
"after",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02352454 | 1:6:chronic_disease,46:54:chronic_disease,56:66:chronic_disease,79:89:chronic_disease,91:116:chronic_disease | Ulcer not of VLU pathophysiology (e.g., pure diabetic, vasculitic, radiation, rheumatoid, collagen vascular disease, pressure, or arterial etiology) | 1 | [
"Ulcer",
"not",
"of",
"VLU",
"pathophysiology",
"(",
"e.g.",
",",
"pure",
"diabetic",
",",
"vasculitic",
",",
"radiation",
",",
"rheumatoid",
",",
"collagen",
"vascular",
"disease",
",",
"pressure",
",",
"or",
"arterial",
"etiology",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
0,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02332369 | 116:139:treatment | Capsular bag tearing beyond the point where the surgeon thinks it is in the best interest of the patient to have a capsular ring implanted | 1 | [
"Capsular",
"bag",
"tearing",
"beyond",
"the",
"point",
"where",
"the",
"surgeon",
"thinks",
"it",
"is",
"in",
"the",
"best",
"interest",
"of",
"the",
"patient",
"to",
"have",
"a",
"capsular",
"ring",
"implanted"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02382549 | 19:40:chronic_disease,, | Participants with uncontrolled diabetes, defined as having a HgB-A1c greater than 7.5% | 1 | [
"Participants",
"with",
"uncontrolled",
"diabetes",
",",
"defined",
"as",
"having",
"a",
"HgB-A1c",
"greater",
"than",
"7.5",
"%"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02843945 | 17:28:treatment,30:42:treatment,47:72:treatment | with concurrent gemcitabine, capecitabine, or infusional 5-fluorouracil | 1 | [
"with",
"concurrent",
"gemcitabine",
",",
"capecitabine",
",",
"or",
"infusional",
"5-fluorouracil"
] | [
0,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02744911 | 1:23:treatment | Bilateral hearing aids (since one free ear is required for use of the SpeechVive device) | 1 | [
"Bilateral",
"hearing",
"aids",
"(",
"since",
"one",
"free",
"ear",
"is",
"required",
"for",
"use",
"of",
"the",
"SpeechVive",
"device",
")"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02595372 | 1:19:treatment | Prior hysterectomy | 1 | [
"Prior",
"hysterectomy"
] | [
1,
1
] |
NCT01750567 | 7:29:chronic_disease | Known diabetes (type 1 or 2) | 1 | [
"Known",
"diabetes",
"(",
"type",
"1",
"or",
"2",
")"
] | [
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02208362 | ,76:101:treatment | An interval of at least 12 weeks must have elapsed since the completion of initial radiation therapy | 1 | [
"An",
"interval",
"of",
"at",
"least",
"12",
"weeks",
"must",
"have",
"elapsed",
"since",
"the",
"completion",
"of",
"initial",
"radiation",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02109081 | 31:41:treatment | anticipation of postoperative intubation | 1 | [
"anticipation",
"of",
"postoperative",
"intubation"
] | [
0,
0,
0,
1
] |
NCT02548104 | 1:13:chronic_disease | coagulopathy (as diagnosed by history or laboratory evaluation) | 1 | [
"coagulopathy",
"(",
"as",
"diagnosed",
"by",
"history",
"or",
"laboratory",
"evaluation",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02945969 | 1:24:treatment | Prior kidney transplant based on self-report | 1 | [
"Prior",
"kidney",
"transplant",
"based",
"on",
"self-report"
] | [
1,
1,
1,
0,
0,
0
] |
NCT01365169 | 21:30:treatment,37:43:cancer,176:200:cancer | Currently receiving treatment for a cancer other than those listed in the arm-specific inclusion criteria (exception: the study does not exclude those receiving treatment for non-melanoma skin cancer) (Arms 2 and 3) | 1 | [
"Currently",
"receiving",
"treatment",
"for",
"a",
"cancer",
"other",
"than",
"those",
"listed",
"in",
"the",
"arm-specific",
"inclusion",
"criteria",
"(",
"exception",
":",
"the",
"study",
"does",
"not",
"exclude",
"those",
"receiving",
"treatment",
"for",
"non-melanoma",
"skin",
"cancer",
")",
"(",
"Arms",
"2",
"and",
"3",
")"
] | [
0,
0,
1,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03076658 | 1:22:chronic_disease | Severe osteoarthritis of the hips/knees/ankles | 1 | [
"Severe",
"osteoarthritis",
"of",
"the",
"hips/knees/ankles"
] | [
2,
2,
0,
0,
0
] |
NCT00001337 | 23:45:chronic_disease,47:68:chronic_disease,72:96:chronic_disease | No active symptomatic ischemic heart disease, myocardial infarction or congestive heart failure within the past year | 1 | [
"No",
"active",
"symptomatic",
"ischemic",
"heart",
"disease",
",",
"myocardial",
"infarction",
"or",
"congestive",
"heart",
"failure",
"within",
"the",
"past",
"year"
] | [
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0
] |
NCT02920710 | 21:38:chronic_disease | Evidence of current serious infection, or a history of chronic or recurring infections | 1 | [
"Evidence",
"of",
"current",
"serious",
"infection",
",",
"or",
"a",
"history",
"of",
"chronic",
"or",
"recurring",
"infections"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01967823 | ,,122:131:treatment | Women of child-bearing potential must have a negative pregnancy test because of the potentially dangerous effects of the treatment on the fetus | 1 | [
"Women",
"of",
"child-bearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"because",
"of",
"the",
"potentially",
"dangerous",
"effects",
"of",
"the",
"treatment",
"on",
"the",
"fetus"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02496663 | 23:32:treatment | patients must also be treatment naive to EGFR-monoclonal antibody | 1 | [
"patients",
"must",
"also",
"be",
"treatment",
"naive",
"to",
"EGFR-monoclonal",
"antibody"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT01597518 | 21:29:allergy_name | Hypersensitivity to riluzole or any of its components | 1 | [
"Hypersensitivity",
"to",
"riluzole",
"or",
"any",
"of",
"its",
"components"
] | [
0,
0,
4,
0,
0,
0,
0,
0
] |
NCT01220583 | ,24:34:chronic_disease | Pre-existing ≥ grade 2 neuropathy | 1 | [
"Pre-existing",
"≥",
"grade",
"2",
"neuropathy"
] | [
0,
0,
0,
0,
2
] |
NCT02135874 | 29:66:cancer | Newly diagnosed or relapsed mixed phenotype acute leukemia (MPAL) | 1 | [
"Newly",
"diagnosed",
"or",
"relapsed",
"mixed",
"phenotype",
"acute",
"leukemia",
"(",
"MPAL",
")"
] | [
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT02620761 | 16:33:chronic_disease,,,,, | No preexisting renal dysfunction, defined as serum creatinine > 1.0 mg/dl, or urine output <1.0 ml/kg/hour over the previous 24 hours | 1 | [
"No",
"preexisting",
"renal",
"dysfunction",
",",
"defined",
"as",
"serum",
"creatinine",
">",
"1.0",
"mg/dl",
",",
"or",
"urine",
"output",
"<",
"1.0",
"ml/kg/hour",
"over",
"the",
"previous",
"24",
"hours"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02382419 | 17:28:treatment | Prior use of an HPV vaccine | 1 | [
"Prior",
"use",
"of",
"an",
"HPV",
"vaccine"
] | [
0,
0,
0,
0,
1,
1
] |
NCT02359825 | 12:24:treatment | undergoing chemotherapy | 1 | [
"undergoing",
"chemotherapy"
] | [
0,
1
] |
NCT02494141 | 1:6:chronic_disease | ADPKD diagnosis | 1 | [
"ADPKD",
"diagnosis"
] | [
2,
0
] |
NCT03006770 | 8:33:treatment,35:46:treatment,48:71:treatment,73:93:treatment,95:109:treatment,149:187:treatment | Use of hyperbaric oxygen therapy, prostanoids, spinal cord stimulation, lumbar sympathectomy, wound dressing containing cells or growth factors, or topical platelet derived growth factor | 1 | [
"Use",
"of",
"hyperbaric",
"oxygen",
"therapy",
",",
"prostanoids",
",",
"spinal",
"cord",
"stimulation",
",",
"lumbar",
"sympathectomy",
",",
"wound",
"dressing",
"containing",
"cells",
"or",
"growth",
"factors",
",",
"or",
"topical",
"platelet",
"derived",
"growth",
"factor"
] | [
0,
0,
1,
1,
1,
0,
1,
0,
1,
1,
1,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02624765 | 1:21:treatment | Antiarrhythmic drugs | 1 | [
"Antiarrhythmic",
"drugs"
] | [
1,
1
] |
NCT02165007 | 31:65:chronic_disease | Patients seropositive for the human immunodeficiency virus (HIV) | 1 | [
"Patients",
"seropositive",
"for",
"the",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] | [
0,
0,
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02510456 | 1:6:cancer, | Tumor size ≥ 2cm, measured on imaging or estimated by physical exam | 1 | [
"Tumor",
"size",
"≥",
"2cm",
",",
"measured",
"on",
"imaging",
"or",
"estimated",
"by",
"physical",
"exam"
] | [
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02302976 | 9:18:treatment | seeking treatment for drug abuse/dependence (for experimental cocaine component) | 1 | [
"seeking",
"treatment",
"for",
"drug",
"abuse/dependence",
"(",
"for",
"experimental",
"cocaine",
"component",
")"
] | [
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03017118 | 13:21:treatment,22:30:treatment,31:37:treatment,38:45:treatment | Patients on Coumadin/Steroids/NSAIDs/Tylenol | 1 | [
"Patients",
"on",
"Coumadin/Steroids/NSAIDs/Tylenol"
] | [
0,
0,
1
] |
Subsets and Splits